Previous close | 15.80 |
Open | 15.80 |
Bid | 18.40 |
Ask | 21.80 |
Strike | 50.00 |
Expiry date | 2024-05-17 |
Day's range | 15.80 - 15.80 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Discover how Twist Bioscience Corp achieved significant revenue growth and margin improvements in Q2 2024, alongside strategic expansions in product offerings and market penetration.
Twist Bioscience (TWST) delivered earnings and revenue surprises of 5.95% and 6.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SOUTH SAN FRANCISCO, Calif., May 02, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the second quarter of fiscal 2024 ended March 31, 2024.